Menu

Experience

David Burns

    • Amryt Pharma to Sell to Chiesi Farmaceutici in $1.48 Billion Cross-Border Transaction  


    • Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion 


    • Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals 


    • ThoughtSpot Brings Valuation to $4.2 Billion With Series F Round 


    • NeoPhotonics Agrees to Sell to Lumentum for $918 Million 


    • Virtual Reality Developer Within Agrees to Sell to Meta 


    • SeatGeek to Combine With SPAC RedBall Acquisition Corp. 


    • Otsuka Enters Worldwide Collaboration Agreement With Sunovion and Sumitomo Dainippon Pharma 


    • Intersect ENT Agrees to Sell to Medtronic for More Than $1 Billion 


    • IRL Reaches Unicorn Status With Series C Round 


    • Snapdocs Valuation Climbs to Over $1.5 Billion With Series D Round 


    • The Honest Company – $475 Million IPO 


    • Five Prime Therapeutics Agrees to Sell to Amgen for $1.9 Billion 


    • Gopuff More Than Doubles Valuation in Five Months With $1.15 Billion Funding Round 


    • Horizon Therapeutics to Acquire Viela Bio 


    • VelosBio Agrees to Sell to Merck for $2.75 Billion 


    • goPuff Hits $3.9 Billion Valuation With Latest Funding Round 


    • Vir Biotechnology - $143 Million IPO 


    • Uber Closes SoftBank Investment 


    • Patheon Prevails in Antitrust Battle with Procaps 


    • NetScout Receives DOJ Clearance After Second Request in $2.6 Billion Acquisition 


    • Auspex Pharma $3.5 billion sale to Teva Pharma 


    • Auspex Pharma Acquired by Teva for $3.5 Billion 


    • Antitrust Team Clears Tesoro for $1.175 Billion Acquisition 


    • Appellate Court Affirms Victory for Patheon in Antitrust Suit with Procaps